These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9240866)

  • 1. Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.
    Mofenson LM
    Acta Paediatr Suppl; 1997 Jun; 421():89-96. PubMed ID: 9240866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of perinatal transmission of human immunodeficiency virus: a progress report 2 years after completion of AIDS Clinical Trials Group trial 076.
    Wilfert CM
    Clin Infect Dis; 1996 Sep; 23(3):438-41. PubMed ID: 8879761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076--results and treatment recommendations.
    Connor EM; Mofenson LM
    Pediatr Infect Dis J; 1995 Jun; 14(6):536-41. PubMed ID: 7667060
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Pediatric AIDS Clinical Trials Group 076 Study Group.
    Shapiro DE; Sperling RS; Coombs RW
    Lancet; 1999 Jul; 354(9173):156; author reply 157-8. PubMed ID: 10408505
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
    Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
    J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
    Carmichael C
    Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
    JAMA; 2002 Feb; 287(8):979-81. PubMed ID: 11871442
    [No Abstract]   [Full Text] [Related]  

  • 9. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV--Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(33):688-91. PubMed ID: 9733415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine and prevention of perinatal HIV transmission.
    Legg JJ; Goldschmidt RH
    Am Fam Physician; 1995 Sep; 52(3):745, 748-50. PubMed ID: 7653413
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of treatment to reduce perinatal human immunodeficiency virus (HIV) transmission and likelihood of testing for HIV: results from two surveys of women of childbearing age.
    Ruiz JD; Molitor F
    Matern Child Health J; 1998 Jun; 2(2):117-22. PubMed ID: 10728267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
    MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
    Wiznia AA; Crane M; Lambert G; Sansary J; Harris A; Solomon L
    JAMA; 1996 May; 275(19):1504-6. PubMed ID: 8622226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in prevention of perinatal HIV-1.
    Fowler MG; Mofenson L
    Acta Paediatr Suppl; 1997 Jun; 421():97-103. PubMed ID: 9240867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group.
    Shapiro DE; Sperling RS; Mandelbrot L; Britto P; Cunningham BE
    Obstet Gynecol; 1999 Dec; 94(6):897-908. PubMed ID: 10576173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal transmission of HIV in women receiving zidovudine: abstract and commentary.
    Mofenson LM
    JAMA; 1998 Aug; 280(6):569-70. PubMed ID: 9707153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.